SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002810
Filing Date
2008-03-14
Accepted
2008-03-14 17:02:04
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183646z10-k.htm 10-K 628577
2 EXHIBIT 3.4 a2183646zex-3_4.htm EX-3.4 98759
3 EXHIBIT 10.41 a2183646zex-10_41.htm EX-10.41 44607
4 EXHIBIT 23.1 a2183646zex-23_1.htm EX-23.1 5888
5 EXHIBIT 31.1 a2183646zex-31_1.htm EX-31.1 7133
6 EXHIBIT 31.2 a2183646zex-31_2.htm EX-31.2 7122
7 EXHIBIT 32.1 a2183646zex-32_1.htm EX-32.1 3351
8 EXHIBIT 32.2 a2183646zex-32_2.htm EX-32.2 3357
9 G988669.JPG g988669.jpg GRAPHIC 20438
  Complete submission text file 0001047469-08-002810.txt   828494
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21243 | Film No.: 08690184
SIC: 2835 In Vitro & In Vivo Diagnostic Substances